Sectra AB (SECT B):企業の財務・戦略的SWOT分析

◆英語タイトル:Sectra AB (SECT B) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C10776
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:55
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Sectra AB (SECT B) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Sectra AB (Sectra) is a medical-technology company. It develops and sells technologies for medical systems and secure communication systems. Its operations are concentrated on two major sectors: Image IT Solutions and Secure Communications. The company’s subsidiary, Sectra Imaging IT Solutions AB, offers medical information technologies, with special expertise in digital image management and picture archiving systems for radiology, mammography, and bone densitometry. Sectra also develops and sells products for secure voice and data communications and other customized systems through its subsidiary Sectra Communications AB. Its products cater to the needs of customers across the world. Sectra is headquartered in Linkoping, Sweden.

Sectra AB Key Recent Developments

Nov 07,2018: U.S. Kettering Health Network selects enterprise imaging from Sectra to increase reading efficiency
Nov 06,2018: Sectra to provide vendor-neutral platform for medical imaging AI project in the UK
Nov 01,2018: Sectra highlights how to handle security vulnerabilities in medical imaging at RSNA 2018
Oct 01,2018: Sectra Tiger to protect NATO secrets from eavesdropping
Oct 01,2018: Sectra Tiger to protect NATO secrets from eavesdropping

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1 – About the Company 6
Sectra AB – Key Facts 6
Sectra AB – Key Employees 7
Sectra AB – Key Employee Biographies 8
Sectra AB – Key Operational Employees 9
Sectra AB – Major Products and Services 10
Sectra AB – History 12
Sectra AB – Company Statement 19
Sectra AB – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Section 2 – Company Analysis 23
Company Overview 23
Sectra AB – Business Description 24
Business Segment: Business Innovation 24
Financials 24
Business Segment: Imaging IT Solutions 24
Financials 24
Business Segment: Other Operations 24
Financials 24
Business Segment: Sectra Customer Financing 24
Financials 24
Business Segment: Secure Communication Systems 25
Financials 25
Sectra AB – SWOT Analysis 26
SWOT Analysis – Overview 26
Sectra AB – Strengths 26
Sectra AB – Weaknesses 27
Sectra AB – Opportunities 28
Sectra AB – Threats 29
Sectra AB – Key Competitors 30
Section 3 – Company Financial Ratios 31
Financial Ratios – Capital Market Ratios 31
Financial Ratios – Annual Ratios 32
Performance Chart 35
Financial Performance 35
Financial Ratios – Interim Ratios 36
Financial Ratios – Ratio Charts 37
Section 4 – Company’s Lifesciences Financial Deals and Alliances 38
Sectra AB, Medical Equipment, Deals By Year, 2012 to YTD 2018 38
Sectra AB, Medical Equipment, Deals By Type, 2012 to YTD 2018 39
Sectra AB, Recent Deals Summary 40
Section 5 – Company’s Recent Developments 41
Nov 07, 2018: U.S. Kettering Health Network selects enterprise imaging from Sectra to increase reading efficiency 41
Nov 06, 2018: Sectra to provide vendor-neutral platform for medical imaging AI project in the UK 42
Nov 01, 2018: Sectra highlights how to handle security vulnerabilities in medical imaging at RSNA 2018 43
Sep 04, 2018: Sectra’s three-month interim report 2018/2019: US success contributes to increased order bookings 44
Aug 21, 2018: Sectra’s medical IT operation receives national computer security certification in the UK 45
Jun 12, 2018: Sectra successfully completes unique nationwide telepathology solution in the Netherlands 46
May 29, 2018: Sectra’s year-end report 2017/2018: Positive earnings trend and healthy order book 47
May 22, 2018: NSW Health, Australia’s Largest Public Health System, has Selected Sectra as Preferred Vendor for a Large Enterprise Imaging IT Solution 48
Apr 12, 2018: Dutch pathology labs can now communicate through nationwide telepathology solution 49
Apr 12, 2018: Sectra: Dutch Pathology Labs can now Communicate Through Nationwide Telepathology Solution 50
Section 6 – Appendix 51
Methodology 51
Ratio Definitions 51
About GlobalData 55
Contact Us 55
Disclaimer 55

List of Tables
Sectra AB, Key Facts 6
Sectra AB, Key Employees 7
Sectra AB, Key Employee Biographies 8
Sectra AB, Key Operational Employees 9
Sectra AB, Major Products and Services 10
Sectra AB, History 12
Sectra AB, Subsidiaries 21
Sectra AB, Key Competitors 30
Sectra AB, Ratios based on current share price 31
Sectra AB, Annual Ratios 32
Sectra AB, Annual Ratios (Cont...1) 33
Sectra AB, Annual Ratios (Cont...2) 34
Sectra AB, Interim Ratios 36
Sectra AB, Medical Equipment, Deals By Year, 2012 to YTD 2018 38
Sectra AB, Medical Equipment, Deals By Type, 2012 to YTD 2018 39
Sectra AB, Recent Deals Summary 40
Currency Codes 51
Capital Market Ratios 51
Equity Ratios 52
Profitability Ratios 52
Cost Ratios 53
Liquidity Ratios 53
Leverage Ratios 54
Efficiency Ratios 54

List of Figures
Sectra AB, Performance Chart (2014 - 2018) 35
Sectra AB, Ratio Charts 37
Sectra AB, Medical Equipment, Deals By Year, 2012 to YTD 2018 38
Sectra AB, Medical Equipment, Deals by Type, 2012 to YTD 2018 39

★海外企業調査レポート[Sectra AB (SECT B):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Stellar Biotechnologies Inc (SBOT)-医療機器分野:企業M&A・提携分析
    Summary Stellar Biotechnologies Inc (Stellar Bio), formerly CAG Capital Inc is a provider of keyhole limpet hemocyanin proteins. The company offers potent immune-stimulating molecule used as an active pharmaceutical ingredient known as active immunotherapies or therapeutic vaccines and as an injecta …
  • Small Industries Development Bank of India:企業のM&A・事業提携・投資動向
    Small Industries Development Bank of India - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Small Industries Development Bank of India Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detai …
  • Abbott Point of Care Inc:企業の製品パイプライン分析2018
    Summary Abbott Point of Care Inc (Abbott Point), a subsidiary of Abbott Laboratories, is a medical device company that offers diagnostic products. The company manufactures, develops, and distributes medical diagnostic and data management products for in-vitro diagnostic and healthcare markets. Its p …
  • 3I Group Plc
    3I Group Plc - Strategy, SWOT and Corporate Finance Report Summary 3I Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Sonoro Energy Ltd (SNV):石油・ガス:M&Aディール及び事業提携情報
    Summary Sonoro Energy Ltd (Sonoro Energy), formerly Sonic Technology Solutions Inc is an oil and gas company that explores, develops and produces asphalt and bitumen resources. It operates Budong Budong Production Sharing Contract on the coast of western Sulawesi, opposite to Balikpapan that offers …
  • Custodian & Allied Plc:企業の戦略・SWOT・財務分析
    Custodian & Allied Plc - Strategy, SWOT and Corporate Finance Report Summary Custodian & Allied Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Affimed GmbH (AFMD):企業の財務・戦略的SWOT分析
    Summary Affimed GmbH (Affimed), formerly Affimed Therapeutics AG, a subsidiary of Affimed NV, discovers and develops immunotherapies to treat hematologic cancers and solid tumors. The company is investigating AFM13, an innate cell engager, for the treatment of Peripheral T cell lymphoma, transformed …
  • The Shipping Corporation of India Ltd (SCI):企業の財務・戦略的SWOT分析
    The Shipping Corporation of India Ltd (SCI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key streng …
  • Complete Genomics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Complete Genomics Inc (Complete Genomics), a subsidiary of BGI Genomics Co Ltd, is a human genome sequencing solutions provider. The company offers sequencing technology, process automation technology and data management solutions. It has sequenced whole human genomes using sequencing instru …
  • Silicon Laboratories Inc (SLAB):企業の財務・戦略的SWOT分析
    Silicon Laboratories Inc (SLAB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Mitsui O.S.K. Lines, Ltd.:企業の戦略・SWOT・財務情報
    Mitsui O.S.K. Lines, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Mitsui O.S.K. Lines, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • GW Pharmaceuticals Plc (GWP):製薬・医療:M&Aディール及び事業提携情報
    Summary GW Pharmaceuticals Plc (GW Pharmaceuticals) is a biopharmaceutical company that discovers, develops and commercializes novel therapeutics from its proprietary cannabinoid product platform. The company’s commercialized product, Sativex is a plant-derived cannabinoid prescription drug, for the …
  • F-Secure Oyj (FSC1V):企業の財務・戦略的SWOT分析
    F-Secure Oyj (FSC1V) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Biofortuna Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Biofortuna Ltd (Biofortuna) is a provider of contract services and molecular diagnostic products. The company distributes CE-marked and freeze-dried PCR diagnostic kits. It has freeze dried molecular diagnostic products targeted at the transplantation, disease identification and pharmacogene …
  • China Medical System Holdings Ltd (867):製薬・医療:M&Aディール及び事業提携情報
    Summary China Medical System Holdings Ltd (CMS) is a pharmaceutical service provider that markets, promotes, and sells prescription drugs to all therapeutic departments in hospitals. The company offers products such as deanxit, ursofalk, augentropfen stulln mono eye-drops, exacin, xinhuosu, salofalk …
  • Range Resources Corporation:企業の戦略・SWOT・財務分析
    Range Resources Corporation - Strategy, SWOT and Corporate Finance Report Summary Range Resources Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Information Analysis Inc (IAIC):企業の財務・戦略的SWOT分析
    Summary Information Analysis Inc (IAI) is a technology company that offers technical solutions. The company offers IT services such as legacy mainframe modernization, database conversion and migration, electronic forms conversion, ebusiness and web based solutions, integrated tablet and mobile appli …
  • Naia Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Naia Ltd (Naia) is a funding and developing company that address regional and global medical needs. The company develops and manufactures therapeutics for metabolic and rare diseases. It provides global drug development through funding, clinical development, organizational structure and regu …
  • Robert Half International Inc. (RHI):企業の財務・戦略的SWOT分析
    Robert Half International Inc. (RHI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Argonaut Gold Inc.:企業の戦略・SWOT・財務情報
    Argonaut Gold Inc. - Strategy, SWOT and Corporate Finance Report Summary Argonaut Gold Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆